In spite of the vast volume of nursing literature that demonstrates how the humanbecoming theory informs nursing practice with persons/ families experiencing loss and grieving, there is very little literature that specifically addresses loss and grieving in the end stage renal disease population.
The author stated that patients with end stage renal disease have complicated issues in relation to mourning, "not necessarily for another, but for the self that was and the life that was" (p.
Despite the enormous benefits of nursing practice guided by the humanbecoming theoretical perspective, there are possible ethical implications that can prove to be challenging for the nephrology nurse when caring for an end stage renal disease patient who is experiencing loss and grieving.
Diabetes is the fastest growing cause of end stage renal disease
Our research and development work on the OLpur H2H and MD filter technologies for End Stage Renal Disease
therapy provided us with the foundations for a proprietary multi-stage water filter that is cost effective, extremely reliable, and long-lasting.
The commercial potential for successful new agents is substantial as existing therapies do not halt the progression of diabetic nephropathy to end stage renal disease
1, plan members will be able to participate in new programs for end stage renal disease, chronic pain and an enhanced maternity management program.
End stage renal disease refers to irreversible kidney failure that requires dialysis or a kidney transplant.
Treatment with NxStage System One is covered by Medicare just like all other hemodialysis treatments as part of the End Stage Renal Disease
Nephros's OLpur(TM) HD190 is designed for use in a variety of End Stage Renal Disease (ESRD) therapies, including hemodialysis (HD) and hemodiafiltration (HDF), and is labeled accordingly.
headquartered in New York, is a medical device company developing and marketing products designed to improve the quality of life for the End Stage Renal Disease (ESRD) patient, while addressing the critical financial and clinical needs of the care provider.
AMEX: NEP), announced today it is initiating supplemental clinical trials across five nations in Europe to demonstrate therapy effectiveness and treatment cost savings achieved through the use of its OLpur(TM) MD190 filter product in providing therapy for chronic End Stage Renal Disease